Ceros Financial Services’s VanEck Biotech ETF BBH Stock Holding History

Ceros Financial Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$70K	Buy	+542	New	+$68.5K	0.02%	143

Other funds holding BBH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Ceros Financial Services's BBH Position: Q1 2019 in Review

Ceros Financial Services opened a new position in VanEck Biotech ETF (BBH) in Q1 2019: 542 shares worth $70K. The stake represents 0.02% of the portfolio and ranks #143 among its holdings.

90 funds tracked by Wall St. Rank hold BBH as of Q1 2019.

Ceros Financial Services held 542 shares of VanEck Biotech ETF worth $70K as of Q1 2019.
VanEck Biotech ETF was a new Ceros Financial Services position in Q1 2019.
VanEck Biotech ETF made up 0.02% of Ceros Financial Services's portfolio in Q1 2019, its #143 holding.
90 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2019.

Based on Ceros Financial Services's 13F filing for Q1 2019, filed 3 May 2019.